Roche Holding AG-Genusschein
13F holders, Q4 2025 (December 31)2holders −2
0new positions
2sold out
$414.26avg. 13F price*
At the end of Q4 2025, 2 institutions reported holding Roche Holding AG-Genusschein in their 13F filings, down 2 from Q3 2025. 0 opened new positions and 2 sold out. The largest holders were Aristotle Capital Management, LLC ($90.7M) and Generali Investments CEE, investicni spolecnost, a.s. ($2.8M).
- Company
- Roche Holding AG-Genusschein
- CUSIP
- H69293217
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 2 | $28.5M |
All 13F filers, Q3 2025 → Q4 2025: 233 shares bought and 89,485 shares sold, net −89,252 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Aristotle Capital Management, LLC | 0.18% | Reduce -1.0% | 218,992 | $90.7M |
| Generali Investments CEE, investicni spolecnost, a.s. | 0.20% | Add +3.5% | 6,871 | $2.8M |
"% of holder's portfolio" is ROCHE HOLDING AG-GENUSSCHEIN's weight in each manager's 13F, not the share of Roche Holding AG-Genusschein the manager owns.